Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients for Management of Refractory Ascites: Clinical Outcome

Keyphrases

• Clinical Outcomes 100%
• Liver Transplant Recipients 100%
• Refractory Ascites 100%
• Transjugular Intrahepatic Portosystemic Shunt 100%
• MELD Score 50%
• Graft Survival 40%
• Ascites 30%
• Portosystemic Gradient 30%
• Transplantation 20%
• Gradient Parameter 20%
• Encephalopathy 20%
• Retrospective Review 10%
• Mortality Rate 10%
• Transplant Recipients 10%
• To Determine the Effectiveness 10%
• New Onset 10%
• Nineteen 10%
• Graft Patency 10%
• Grafting Ratio 10%
• Graft Loss 10%
• Liver Disease 10%
• Patency 10%
• Significant Indicators 10%
• Kaplan-Meier Method 10%
• Thirty-day Mortality 10%
• 90-day Mortality 10%
• Technical Success 10%
• Clinical Success Rate 10%
• Mean Model 10%
• Native Liver 10%
• Portal Hypertension 10%
• Clinical Efficacy 10%

Medicine and Dentistry

• Liver Graft 100%
• Transjugular Intrahepatic Portosystemic Shunt 100%
• Ascites 100%
• Shunt Creation 70%
• Graft Survival 50%
• Model For End Stage Liver Disease Score 50%
• Brain Disease 20%
• Hemodynamic 10%
• Graft Failure 10%
• Mortality Rate 10%
• Graft Patency 10%
• Survival Rate 10%
• Kaplan Meier Method 10%
• Liver Disease 10%
• Portal Hypertension 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Ascites 100%
• End Stage Liver Disease 100%
• Brain Disease 40%
• Liver Disease 20%
• Mortality Rate 20%
• Survival Rate 20%
• Graft Failure 20%
• Portal Hypertension 20%